Related Experiment Videos

Chronic hepatitis C: less of a problem than first thought?

Graham R Foster¹

¹Blizard Institute, Queen Mary University of London, London, UK.

The Lancet. Gastroenterology & Hepatology

|April 14, 2017

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Can real-world scaling up HCV treatment in people who inject drugs be cost-saving: an economic modelling study in the UK.

The International journal on drug policy·2026

Correction: Hepatitis C virus cascade of care among adults in Sindh province, Pakistan: Findings from 2019-2020 household sero-survey.

PLOS global public health·2026

The Impact of Hepatitis C and Socio-Demographic Variables on Health-Related Quality of Life in Pakistan: Cross-Sectional Study.

Journal of viral hepatitis·2026

The impact and cost-effectiveness of scaling up HCV treatment for achieving elimination among people who inject drugs in England: a synopsis including evidence synthesis and economic modelling.

Health technology assessment (Winchester, England)·2026

Evaluating hepatocellular carcinoma (HCC) surveillance through an early diagnostic centre: An implementation science approach at a tertiary hepatology centre in England.

Clinical medicine (London, England)·2025

Hepatitis C: current treatments, emerging therapies and tackling health inequities on the path to global elimination.

Clinical medicine (London, England)·2025

See all related articles